XYD113
XYD113 is an orally active, selective GSPT1 Molecular glue degrader. XYD113 promotes the formation of the CRBN-GSPT1 ternary complex and mediates GSPT1 degradation in a CRBN-dependent manner via the ubiquitin-proteasome system. XYD113 downregulates genes associated with the occurrence and progression of prostate cancer (c-Myc, AR, AR-V7, KLK3, KLK2, TMPRSS2). XYD113 exhibits anticancer activity against prostate cancer. XYD113 can be used in the research of prostate cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 3032314-99-8
- 分子式: C21H21ClN4O4
- 分子量:428.87
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
|
AR-V7 |
KLK3 |
KLK2 |
TMPRSS2 |
CRBN |
XYD113 (96 h) potently inhibits the proliferation of 22Rv1 cells, with an IC50 of 69 nM[1].
XYD113 (12-1000 nM; 1-12 h) induces dose- and time-dependent degradation of GSPT1 in 22Rv1 cells, with potency comparable to that of MRT-2359 (HY-153356); meanwhile, this compound shows high selectivity, as it does not degrade SALL4, IKZF1/2/3, ZFP91 or CK1α even at a concentration of 1 μM[1].
XYD113 (100-500 nM; 12 h) effectively downregulates the expression of genes critical for prostate cancer initiation and progression in 22Rv1 cells when applied at concentrations of 100 nM and 500 nM for 12 h[1].
As a molecular glue, XYD113 (0.1-100 μM; 1.5 h) promotes the formation of the CRBN-GSPT1 ternary complex in a concentration-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human prostate cancer 22Rv1 cells
-
Concentration:range of concentrations
-
Incubation Time:96 h
-
Result:Potently inhibited 22Rv1 cell proliferation with an IC50 of 69 nM.
-
Cell Line:human prostate cancer 22Rv1 cells
-
Concentration:12-1000 nM (6 h incubation); 100 nM (1-12 h incubation); 1 μM (6 h incubation)
-
Incubation Time:6 h (12-1000 nM, 1 μM); 1-12 h (100 nM)
-
Result:Induced complete degradation of GSPT1 at 1 μM after 6 h.
Reduced GSPT1 protein levels in a dose-dependent manner across 12-1000 nM after 6 h.
Reduced GSPT1 protein levels in a time-dependent manner across 1-12 h at 100 nM.
Showed no significant degradation of off-target substrates SALL4, IKZF1, IKZF2, IKZF3, ZFP91, or CK1α even at 1 μM after 6 h.
-
Cell Line:human prostate cancer 22Rv1 cells
-
Concentration:100-500 nM
-
Incubation Time:12 h
-
Result:Significantly downregulated mRNA expression levels of c-Myc, AR, AR-V7, KLK3, KLK2, and TMPRSS2.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c-nude (5 weeks old)[1]
-
Dosage:5 mg/kg
-
Administration:p.o.; daily; 21 days
-
Result:Achieved a tumor growth inhibition (TGI) rate of 46%.
Showed no significant body weight loss during treatment.
Caused significant downregulation of GSPT1 protein levels in harvested tumor tissues.
Revealed no tissue abnormalities in major organs (heart, liver, spleen, lung, kidney) compared to vehicle control.
化学情報
-
CAS 番号 3032314-99-8
-
分子量 428.87
-
分子式 C21H21ClN4O4
-
SMILES
ClC1=CC(NC(NCC2=CC=CC(C(NC3CCC(NC3=O)=O)=O)=C2)=O)=CC=C1C
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
XYD113 関連分類
HY-184896 関連分類
Powered by Bioz